ArticleJNCI cancer spectrum2023

Assessing the impact of open-label designs in patient-reported outcomes: investigation in oncology clinical trials.

Jennifer Lord-Bessen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.